Literature DB >> 9090750

Inhibitory effects of tetrandrine and hernandezine on Ca2+ mobilization in rat glioma C6 cells.

K Imoto1, H Takemura, C Y Kwan, S Sakano, M Kaneko, H Ohshika.   

Abstract

The effects of tetrandrine (TET), a Ca2+ antagonist of Chinese herbal origin, and hernandezine (HER), a structural analogue of TET, on Ca2+ mobilization were studied in rat glioma C6 cells. TET and HER alone did not affect the resting cytoplasmic Ca2+ concentration ([Ca2+]i). TET and HER inhibited the peak and sustained elevation of [Ca2+]i induced by bombesin and thapsigargin (TG), a microsomal Ca2+ ATPase inhibitor, in a dose-dependent manner. The doses of TET or HER needed to abolish the sustained and peak increase in [Ca2+]i induced by bombesin and TG were 30 microM and 300 microM, respectively. TET and HER did not increase inositol 1,4,5-trisphosphate (IP3) accumulation by themselves but inhibited IP3 accumulation elevated by bombesin. In permeabilized C6 cells, the addition of IP3 and TG released Ca2+ from intracellular stores. Pretreatment with TET or HER abolished Ca2+ release from intracellular stores induced by bombesin and TG. In the absence of extracellular Ca2+, the addition of 3 mM Ca2+ to extracellular medium slightly increased [Ca2+]i, which indicated Ca2+ entry due to leakage of Ca2+ at the plasma membrane but not Ca2+ influx through Ca2+ channels. TET and HER did not affect this leakage entry of Ca2+. The present results suggest that TET and HER inhibit Ca2+ release from intracellular stores as well as Ca2+ entry from extracellular medium evoked by bombesin and TG. In addition, TET and HER inhibit IP3 accumulation induced by bombesin in rat glioma C6 cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9090750

Source DB:  PubMed          Journal:  Res Commun Mol Pathol Pharmacol        ISSN: 1078-0297


  5 in total

Review 1.  Pharmacology of tetrandrine and its therapeutic use in digestive diseases.

Authors:  D G Li; Z R Wang; H M Lu
Journal:  World J Gastroenterol       Date:  2001-10       Impact factor: 5.742

2.  Effects of tetrandrine on glioma cell malignant phenotype via inhibition of ADAM17.

Authors:  Zhichao Wu; Guangzhi Wang; Shaoqian Xu; Yang Li; Yu Tian; Hongshuang Niu; Fei Yuan; Fenggang Zhou; Zhen Hao; Yongri Zheng; Qingsong Li; Jianjiao Wang
Journal:  Tumour Biol       Date:  2013-11-03

3.  Interaction Effects between Doxorubicin and Hernandezine on the Pharmacokinetics by Liquid Chromatography Coupled with Mass Spectrometry.

Authors:  Yang Song; Yuan Zhang; Wei-Peng Zhang; Bao-Zhen Zhang; Ke-Fei Wang; Xue-Song Feng
Journal:  Molecules       Date:  2019-10-08       Impact factor: 4.411

4.  Antitumor activity of tetrandrine citrate in human glioma U87 cells in vitro and in vivo.

Authors:  Jingyu Sun; Yang Zhang; Yongzhan Zhen; Ju Cui; Gang Hu; Yajun Lin
Journal:  Oncol Rep       Date:  2019-10-15       Impact factor: 3.906

Review 5.  Bombesin Receptor Family Activation and CNS/Neural Tumors: Review of Evidence Supporting Possible Role for Novel Targeted Therapy.

Authors:  Terry W Moody; Lingaku Lee; Irene Ramos-Alvarez; Tatiana Iordanskaia; Samuel A Mantey; Robert T Jensen
Journal:  Front Endocrinol (Lausanne)       Date:  2021-09-01       Impact factor: 5.555

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.